| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 3151 |
14:0 PC-d63|1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 |
561 |
axc |
2023-04-10 |
| 3152 |
16:0 PC-d4|1,2-dipalmitoyl-sn-glycero-3-phosphocholine-1,1,2,2-d4磷脂 |
589 |
axc |
2023-04-10 |
| 3153 |
16:0 PC-d62|1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine磷脂 |
580 |
axc |
2023-04-10 |
| 3154 |
16:0-d31-18:1 PC|1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine 磷脂 |
582 |
axc |
2023-04-10 |
| 3155 |
N3-PEG6-CH2COOH 880129-82-8 Azide-PEG6-CH2COOH PEG试剂 |
546 |
LYQ |
2023-04-10 |
| 3156 |
16:0-Pyr PC|1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphatidylcholine|PC磷脂 |
1233 |
axc |
2023-04-10 |
| 3157 |
18:1(11-cis) PC|1,2-divaccenoyl -sn-glycero-3-phosphocholine|PC磷脂 |
537 |
axc |
2023-04-10 |
| 3158 |
16:1 (Δ9-Trans) PC|1,2-dipalmitelaidoyl-sn-glycero-3-phosphocholine|PC磷脂 |
648 |
axc |
2023-04-10 |
| 3159 |
18:1 (Δ9-Trans) PC|1,2-dielaidoyl-sn-glycero-3-phosphocholine|PC磷脂 |
1226 |
axc |
2023-04-10 |
| 3160 |
06:0 Lyso PC|1-hexanoyl-2-hydroxy-sn-glycero-3-phosphocholine 磷脂PC |
636 |
axc |
2023-04-07 |
| 3161 |
2-18:1 Lyso PC|1-hydroxy-2-oleoyl-sn-glycero-3-phosphocholine PC类磷脂 |
538 |
axc |
2023-04-07 |
| 3162 |
20:0 Lyso PC|1-arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine PC类磷脂 |
540 |
axc |
2023-04-07 |
| 3163 |
N3-PEG4-SPA 944251-24-5 PEG修饰剂 |
590 |
LYQ |
2023-04-07 |
| 3164 |
聚偏二氟乙烯/聚丙烯腈海水淡化膜 ，聚偏二氟乙烯/共六氟丙烯海水淡化膜 |
640 |
zyl |
2023-04-06 |
| 3165 |
mPEG6-N3 1043884-49-6 PEG修饰剂 |
577 |
LYQ |
2023-04-06 |
| 3166 |
酶抑制剂靶点预测|药物靶点评估|化合物库定制 |
817 |
zyl |
2023-04-04 |
| 3167 |
细胞膜修饰脂质体/蛋白/聚合物纳米载体/磁性纳米粒子 |
573 |
zyl |
2023-04-04 |
| 3168 |
cas:90429-66-6 Tempol-d17,15N 活性氧簇 |
638 |
axc |
2023-04-04 |
| 3169 |
Topo I/COX-2-IN-2 活性氧抑制剂运输条件 |
616 |
axc |
2023-04-04 |
| 3170 |
CAS：2133360-04-8 Pomalidomide-NH-CO-PEG1-N3 PEG衍生物 |
640 |
LYQ |
2023-04-04 |
| 3171 |
PEG衍生物 Thalidomide-O-PEG4-N3 2380318-57-8 萨力多胺-O-四聚乙二醇-叠氮 |
598 |
LYQ |
2023-04-04 |
| 3172 |
cas:2402735-14-0 DPP-4-IN-3 抗氧化小分子 |
550 |
axc |
2023-04-04 |
| 3173 |
cas:38216-54-5 Aureusidin 抗氧化抑制剂 |
581 |
axc |
2023-04-03 |
| 3174 |
cas:121009-77-6 Simvastatin acid 分子量436.58 活性氧 |
549 |
axc |
2023-04-03 |
| 3175 |
Biotin-PEG6-OH 906099-89-6 小分子PEG |
545 |
LYQ |
2023-04-03 |
| 3176 |
1.计算机辅助药物设计-活性/药物筛选 |
687 |
zyl |
2023-04-03 |
| 3177 |
关于PEG制备方法的简单介绍 |
921 |
LYQ |
2023-03-31 |
| 3178 |
Reactive oxygen species（ROS）活性氧响应的新型阳离子共聚物 |
1006 |
zyl |
2023-03-30 |
| 3179 |
ROS浓度高低对细胞的影响，为什么要测ROS？ |
6413 |
zyl |
2023-03-30 |
| 3180 |
硫醇过氧化物酶在ROS信号传递中的作用 |
1105 |
zyl |
2023-03-30 |
| 3181 |
ROS活性氧有哪些检测方法？ |
1133 |
zyl |
2023-03-29 |
| 3182 |
活性氧Reactive Oxygen Species，ROS检测 |
634 |
zyl |
2023-03-29 |
| 3183 |
cas:916888-49-8 L-Acetyldopamine dimer-2 抗氧化抑制剂 |
597 |
axc |
2023-03-29 |
| 3184 |
cas:101314-97-0 Simvastatin hydroxy acid sodium辛伐他汀钠盐活性氧分子 |
675 |
axc |
2023-03-29 |
| 3185 |
Indirubin-3′-oxime Cas号：667463-82-3 Reactive Oxygen Species |
1004 |
LYQ |
2023-03-29 |
| 3186 |
cas:102841-46-3 Moracin P 桑辛素P 活性氧抑制剂 |
655 |
axc |
2023-03-29 |
| 3187 |
cas:109-57-9 Allylthiourea 烯丙基硫脲 活性氧抑制剂 |
674 |
axc |
2023-03-28 |
| 3188 |
cas:16724-03-1 2-Selenouracil 活性氧簇 |
545 |
axc |
2023-03-28 |
| 3189 |
cas:28282-25-9 β-Elemonic acid β-岚香酮酸 ROS小分子 |
608 |
axc |
2023-03-28 |
| 3190 |
cas:113170-55-1 L-Ascorbic acid 2-phosphate magnesium 维生素C磷酸酯镁抗氧化抑制剂 |
792 |
axc |
2023-03-28 |
| 3191 |
cas:2031170-96-2 HKOH-1 抗氧化抑制剂 |
545 |
axc |
2023-03-28 |
| 3192 |
Cas号：228559-41-9 Ki8751 VEGFR2抑制剂(KI8751) 活性氧物种 |
643 |
LYQ |
2023-03-28 |
| 3193 |
Cas号：4338-47-0 Kinetin riboside 动力精核苷 活性氧物种 |
504 |
LYQ |
2023-03-28 |
| 3194 |
活性氧物种 Cas号：1589527-65-0 kira6 IRE1Α RNASE激酶抑制剂(KIRA6) |
584 |
LYQ |
2023-03-28 |
| 3195 |
Cas号：24047-25-4 胍诺沙苄 Guanoxabenz Reactive Oxygen Species |
574 |
LYQ |
2023-03-27 |
齐岳微信公众号
官方微信
库存查询